Novo Nordisk is applying for an expanded US label for its long-acting insulin Tresiba, hoping to gain an upper hand on Sanofi's older rival Lantus. Its data submitted to the FDA shows that ...

She had to ring various local pharmacies before tracking down one with stocks of Humalog vials — her usual form of insulin. Health officials are aware of issues affecting Tresiba, Insulatard ...

Findings from CONFIRM - a large real-world evidence study - compared the effectiveness of Tresiba injections versus insulin glargine U300, marketed as Toujeo and sold by Sanofi. The study included ...